Biologically, fear (the feeling of a discrete threat that is exerted, for instance by a person or object) and anxiety (the diffuse sensation of being scared, for instance in a situation that is considered unsafe) are important features within the spectrum of our behaviors: they advise us to avoid unpleasant situations and protect us from influences that are potentially harmful. Indeed, everybody learns by social interaction or painful experience to fear and avoid certain behaviors or encounters that might interfere with one's well-being. As already pointed out by Charles Darwin in 1872 (C. Darwin."The expression of the emotions in man and animals". John Murray, London, 1872), these phylogenetically ancient behavioral features ("horror and agony") exist in all mammals, most probably in all vertebrates. The early origin in phylogeny and the positive selection in evolution of these behaviors are readily comprehensible: individuals who react with caution and care have a higher chance of survival in a dangerous environment. One example is the rabbit, who is often blamed for being too anxious, but who is the symbol of longevity in Chinese mythology. Or, conversely: "the brave are always the first to die".
However, extreme alterations in or distortions to these behavioral mechanisms may trigger disproportional and prolonged (even irreversible) states of fear and anxiety that are difficult to cope with and control by those affected: such states are experienced, for instance, as excessive fear with respect to the triggering stimulus, persistence of anxiety following withdrawal of the stimulus or omnipresent generalized anxiety. This sort of maladaptive anxiety likely reflects an underlying pathology, an anxiety disorder, requiring treatment. Examples include panic disorders, phobias, posttraumatic stress disorders, and generalized anxiety disorders. Now is the age of anxiety (W.H. Auden."The age of anxiety: a baroque eclogue". Random House, New York, 1947) . Although this baroque text by Wystan Hugh Auden won the Pulitzer Award more than 60 years ago, its message still holds true at the beginning of the 21 st century: the number of patients suffering from anxiety disorders is alarming, with a lifetime prevalence of 14%-29% (in the European Union) and early symptoms often occurring before the age of 11 years. In fact, anxiety disorders are ranked among the most frequent psychiatric disorders, as well as among those with the earliest disease onset. Such a disease has a dramatic impact on quality of life, learning and other intellectual capabilities, including ability to work and socially interact. The disease results from a complex interaction between genetic disposition, psycho-social and autobiographical influences (life history), and neuropathological alterations within the "fear circuits" of the brain. Unfortunately, the etiology and pathogenesis of anxiety disorders remain largely unknown, making diagnosis difficult and therapy often not particularly successful. Results from epidemiological studies clearly demonstrate the tremendous economic impact of anxiety disorders, posing a major challenge to health providers and putting a burden on the economy.
Any attempt at systematic scientific analyses of these emotions and their pathological alterations requires combined approaches involving neurobiology, genetics, psychology and psychiatry, all of which should converge into an overall translational concept. This scientific concept should aim at the identification of detailed mechanisms, often implying a reductionistic approach. This concept should also allow translational approaches, which pave the way for novel avenues in diagnosis, therapy and identification of individual risk profiles for the disease. These are the strategic lines along which the Transregional Collaborative Research Center "Fear, Anxiety, Anxiety Disorders (SFB-TRR58)" was designed, established and funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) in July 2008, and extended into the second funding period in 2012 (http://sfbtrr58.uni-muenster.de/). The center joins scientists from the Universities of Münster, Hamburg and Würz-burg, and an associated group at Mainz University. These scientists contribute scientific expertise in molecular biology, genetics, neurophysiology, behavioral biology, psychology, psychiatry and imaging. This concentration of expertise and interdisciplinary collaboration is truly unique in this field of research. It provides the basis for a scientific strategy that unifies concepts of animal experimental and human studies, allowing for mutual interactions and interdisciplinary approaches. This, in turn, is the single most important precondition for the identification of molecular and systemic mechanisms of fear, anxiety and anxiety disorders, not just in incremental steps but in principle categories. At present, the SFB-TRR58 is composed of 19 research projects, which are organized into three research areas and one central area: (A) Experimental Animal Studies, (B) Preclinical Studies, (C) Clinical Translation and Intervention, (Z02) Functional Genomics and Gene x Environment Interaction.
The scientific strategy of the SFB-TRR58 research program has been composed along two major lines. Along one line, we focus on selected models, mechanisms and disorders, generating convergent approaches from various analytical levels to achieve maximal synergy. Along a second line, we have implemented screening approaches aimed at identifying candidate genes and "innovative" genes related to anxiety disorders. After having identified a particular critical gene, its relevance is verified in a sort of "proofof-principle" approach, making use of the established experimental models and concepts, where knowledge of the detailed functions is an important precondition for deciphering the impact of the genetic influence and gene x environment interaction. Our major aims are: (i) to integrate molecular and cellular components into the concerted action of the fear-relevant synaptic networks, (ii) to identify involved brain regions and behavioral correlates, (iii) to understand gene x environmental influences on these functions and, finally, (iv) to deduce conclusions paving the way for improvement of clinical diagnosis and treatment.
This special edition of Neuroforum provides some insight into the research areas of our center. Carsten Wotjak and HansChristian Pape introduce some of the synaptic circuits that are key to fear, anxiety and fear extinction. Norbert-Sachser and Klaus-Peter Lesch explain the significance of gene x environment interactions using animals models of excessive fear and anxiety as examples. Next, Evelyn GlotzbachSchoon, Marta Andreatta,Andreas Müh-lberger andPaul Pauli demonstrate how virtual reality paradigms are designed in close analogy to animal studies, which serve as models for pathological fear in humans. Katharina Domschke extends the preclinical findings on the molecular basis of fear and anxiety towards the role of genetic factors and environmental influences for pathogenesis in humans by describing a novel vulnerability gene and demonstrating its relevance to anxiety disorders.
An integral part of the scientific work of the SFB-TRR58 is a Young Researchers Concept, which involves the coordinated graduate programs with relevant topics and techniques at the participating universities. Investigators of the SFB-TRR58, in turn, contribute their expertise to these programs. In addition, the SFB-TRR58 offers young people ways to explore the possibilities of neuroscientific research. One example is the"Pupils Lab", where classes and courses are directly held in the lab, complemented by lectures by SFB scientists given to high school biology classes.
Overall, by linking research on fear, anxiety and anxiety disorders at three universities, the SFB-TRR58 forms a major part of the scientific profile of these universities, generates important scientific contributions to the field and heads educational programs in the field of neurobiology of emotion. As a corollary, the SFB-TRR58 aims to direct a "new" generation of scientists towards emotional research in order to obtain a deeper knowledge of the mechanistic principles of fear and anxiety. We expect these results to lead the way towards a significant improvement in the prognosis, diagnosis and therapy of anxiety disorders.
Thanks are due to the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) for their funding of our scientific work, as well as to all members of the SFB-TRR58 who form and propel this collaborative project.
